CLINICAL BENEFITS AND MECHANISMS OF A SUSTAINED RESPONSE TO INTERMITTENT INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE

被引：61
|
作者：
YKIJARVINEN, H
ESKO, N
EERO, H
MARJARIITTA, T
机构：
[1] UNIV HELSINKI,DEPT MED 2,SF-00100 HELSINKI 10,FINLAND
[2] UNIV HELSINKI,DEPT MED 3,SF-00100 HELSINKI 10,FINLAND
来源：
AMERICAN JOURNAL OF MEDICINE | 1988年 / 84卷 / 02期
关键词：
D O I：
10.1016/0002-9343(88)90412-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 192
页数：8
相关论文
共 50 条
  • [21] INSULIN SUPPLEMENT IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY FAILURE TO ORAL-AGENTS AMELIORATES HEPATIC AND PERIPHERAL INSULIN SENSITIVITY BUT NOT INSULIN-SECRETION
    PISU, E
    DEBENEDICTIS, D
    BAGGIORE, C
    DIANA, A
    MARENGO, C
    BOZZO, C
    RENZETTI, A
    PAGANO, G
    DIABETIC MEDICINE, 1990, 7 (09) : 805 - 809
  • [22] BLOOD-GLUCOSE CONTROL AND INSULIN-SECRETION IMPROVED WITH COMBINED THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS
    IAVICOLI, M
    CUCINOTTA, D
    DEMATTIA, G
    LUNETTA, M
    MORSIANI, M
    PONTIROLI, AE
    POZZA, G
    DIABETIC MEDICINE, 1988, 5 (09) : 849 - 855
  • [23] WINE FOR TYPE-2 DIABETIC-PATIENTS
    CHRISTIANSEN, C
    THOMSEN, C
    RASMUSSEN, O
    BALLE, M
    HAUERSLEV, C
    HANSEN, C
    HERMANSEN, K
    DIABETIC MEDICINE, 1993, 10 (10) : 958 - 961
  • [24] METABOLIC-CLEARANCE RATE OF INSULIN IN TYPE-2 DIABETIC-PATIENTS TREATED WITH COMBINED INSULIN AND SULFONYLUREA THERAPY
    CASTILLO, MJ
    SCHEEN, AJ
    LEFEBVRE, PJ
    REVISTA ESPANOLA DE FISIOLOGIA, 1994, 50 (01): : 27 - 34
  • [25] OCTREOTIDE INFUSION REDUCED INSULIN REQUIREMENT IN TYPE-2 DIABETIC-PATIENTS WITH CHRONIC-RENAL-FAILURE
    SPANTI, D
    LUNETTA, M
    DIMAURO, M
    LEMOLI, R
    SPATA, C
    INFANTONE, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 456 - 456
  • [26] ONE-YEAR DOUBLE-BLIND-STUDY WITH COMBINED THERAPY OF GLIBENCLAMIDE AND INSULIN IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH SECONDARY SULFONYLUREA FAILURE
    BRUNS, W
    SCHEIBE, M
    WILLKOMMEN, G
    HILDEBRANDT, R
    DIABETOLOGIA, 1987, 30 (07) : A504 - A504
  • [27] INSULIN RESISTANCE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH HYPERTRIGLYCERIDEMIA
    WIDEN, E
    EKSTRAND, A
    SALORANTA, C
    FRANSSILAKALLUNKI, A
    ERIKSSON, J
    SCHALINJANTTI, C
    GROOP, L
    DIABETOLOGIA, 1992, 35 (12) : 1140 - 1145
  • [28] TWICE DAILY INSULIN THERAPY IN PATIENTS WITH TYPE-2 DIABETES AND SECONDARY FAILURE TO SULFONYLUREAS
    WOLFFENBUTTEL, BHR
    WEBER, RFA
    WEEKS, L
    VANKOETSVELD, PM
    VERSCHOOR, L
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1990, 13 (02): : 79 - 84
  • [29] SULFONYLUREA THERAPY DOUBLES B-CELL RESPONSE TO GLUCOSE IN TYPE-2 DIABETIC-PATIENTS
    HOSKER, JP
    BURNETT, MA
    DAVIES, EG
    HARRIS, EA
    TURNER, RC
    DIABETOLOGIA, 1985, 28 (11) : 809 - 814
  • [30] ANTIHYPERTENSIVE THERAPY WITH ENALAPRIL IMPROVES GLUCOSE STORAGE AND INSULIN SENSITIVITY IN HYPERTENSIVE TYPE-2 DIABETIC-PATIENTS
    VUORINENMARKKOLA, H
    YKIJARVINEN, H
    DIABETOLOGIA, 1992, 35 : A93 - A93
12345